OniX OnPoint Issue #39: Influenza Innovation Spotlight
Advancing the Fight Against Influenza: From Broadly Neutralizing Antibodies to Novel Antiviral Therapies
This week's OniX OnPoint highlights cutting-edge research and development in influenza prevention and treatment. Featured projects include breakthrough broadly neutralizing antibodies targeting conserved hemagglutinin regions, novel host-pathogen interaction studies exploring viral activation mechanisms, innovative metabolic therapies against highly pathogenic strains, and promising nucleoside-based antivirals. The collection showcases international collaboration across academic institutions, research centers, and biotech companies working to address seasonal influenza challenges and prepare for potential pandemic threats, particularly focusing on H5N1 avian influenza.
Keep reading with a 7-day free trial
Subscribe to OniX OnPoint Newsletter to keep reading this post and get 7 days of free access to the full post archives.